Inventor · disambiguated record
Xuewei Liu
Also filed as: LIU XUEWEI
7 granted patents·4 pending applications·10 citations·filing 2003–2022
76Inventor score
Files withUNIV NANYANG TECH4CHUGAI PHARMACEUTICAL CO LTD1EBETINO FRANK H1LIU XUEWEI1PROCTER & GAMBLE1
Top patents by PatentIndex Score
11 records- 0170US12036195B2Co-crystals of NURR1-lbd in complex with a cyclopentenone prostaglandin and modulators of NURR1UNIV NANYANG TECH·Filed 2022·Granted Jul 16, 2024·0 cites·3 claims
- 0269US8304553B2Method of forming oseltamivir and derivatives thereofLIU XUEWEI·Filed 2008·Granted Nov 6, 2012·5 cites·21 claims
- 0366US7696365B2Heterocyclic compounds useful as malonyl-CoA decarboxylase inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Granted Apr 13, 2010·3 cites·5 claims
- 0465US7026335B2Melanocortin receptor ligandsPROCTER & GAMBLE·Filed 2003·Granted Apr 11, 2006·2 cites·9 claims
- 0558US9112226B2Anode material for ultrafast-charging lithium ion batteries and a method of its synthesisUNIV NANYANG TECH·Filed 2013·Granted Aug 18, 2015·0 cites·12 claims
- 0655US11406610B2Co-crystals of Nurr1-LBD in complex with a cyclopentenone prostaglandin and modulators of Nurr1UNIV NANYANG TECH·Filed 2017·Granted Aug 9, 2022·0 cites·2 claims
- 0750US2024091172A1Drug for antagonizing replication of porcine reproductive and respiratory syndrome virus and application thereofUNIV NANJING AGRICULTURAL·Filed 2020·Application pending·0 cites
- 0849US2005239835A1Melanocortin receptor ligandsEBETINO FRANK H·Filed 2005·Application pending·0 cites
- 0948US12378328B2Biohybrid peptidoglycan oligomersUNIV NANYANG TECH·Filed 2019·Granted Aug 5, 2025·0 cites·20 claims
- 1048US2005171158A1Melanocortin receptor ligandsFiled 2005·Application pending·0 cites
- 1148US2004010010A1Melanocortin receptor ligandsFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xuewei Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →